![](https://investorshub.advfn.com/uicon/735854.png?cb=1621011866)
Friday, April 24, 2020 9:18:29 PM
The language the SEC accused them of: “DECN’s statements claiming to have “technology perfected” to allow it to manufacture and sell a COVID-19 test kit that would provide results “in 15 seconds, based on a small finger prick blood sample,”
3/3
“Keith Berman, CEO of DECN commented, "We have the technology perfected which will take months off of the development schedule.”
Added bonus: “Later product entries will be test methods for Polio, Ebola (Marburg), Bird Flu, and SARS.” Literally adaptable to just about any type of virus – IF this works, it is a game-changer for the entire testing industry.
3/4
“What makes the testing for the Coronavirus possible, and the GenUltimate TBG special, is the company's Impedance measurement technology.”
3/11
“Keith Berman, CEO of DECN commented, "Because we perfected the Impedance technology in 2019 for our GenUltimate TBG glucose test strip and meter, we have shaved months off of the development time for the GenViro! device.”
You judge the meaning. Perfected IN 2019!
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM